Information aids influence more to get screened for colon cancer

November 6, 2012 by Glenda Fauntleroy

People who are given information tools to help them decide whether to have a colorectal cancer screening test are more likely to request the procedure, finds a new study in the American Journal of Preventive Medicine.

While colorectal cancer remains a leading cause of cancer-related death, the number of deaths has dropped over the past 20 years, according to the . The decrease is partly attributed to the fact that more people are receiving screening tests that catch sooner.

Researchers say that while decision-aid tools, such as descriptive videos and pamphlets, can help convince even more people to be tested, they aren't widely used yet.

"Although decision support tools such as ours have gained popularity, actual implementation into clinical practice has lagged because of perceived barriers related to the disruption of workflow in the clinic, time and potential costs," said lead author Paul C. Schroy, M.D., professor of medicine at Boston University School of Medicine.

The study included 825 primary care patients 50 to 75 years old with no symptoms and an average risk of , who were randomly divided into one of two intervention groups and one control group. During a routine visit with their , patients in the two intervention groups viewed a decision-aid video on the benefits and methods of or the video plus a personalized with feedback. Those in the control group were shown a generic healthy lifestyle video.

Patients were then queried 6 and 12 months after their office visit. The number of patients who completed a colorectal cancer screening test was about 8 percent higher for those in the decision aid group compared with the control group (43.1 vs. 34.8 percent, respectively)—which the researchers considered to be a "moderate impact" on .

"Decision aids are particularly useful when there is not a clear right or wrong treatment choice," explained Jennifer McClure, Ph.D., associate director of research at Group Health Research Institute in Seattle. "They can help patients make decisions that are well aligned with their personal values and health goals in the face of competing options, each of which has pros and cons." Decision aids are designed to complement rather than replace counseling from physicians.

Lead researcher Schroy said the challenge still remains to convince providers to implement decision aids into their practices outside of the context of a clinical trial.

"Until such time that the barriers can be addressed, we assume that physicians are more likely to utilize the more traditional, albeit less effective, verbal discussion," he said. 

Explore further: ACP releases new colorectal cancer screening guidance statement

More information: Schroy PC, Emmons KM, Peters E, et al. Aid-assisted decision-making and colorectal cancer screening: a randomized controlled trial. American Journal of Preventive Care. In Press, 2012.

Related Stories

ACP releases new colorectal cancer screening guidance statement

March 5, 2012
The American College of Physicians (ACP) today issued a new guidance statement for colorectal cancer screening. Colorectal cancer is the second leading cause of cancer-related deaths for men and women in the United States. ...

Study shows colorectal cancer screening rates high in patients with multiple health problems

March 20, 2012
A study by University of Kentucky researchers showed that in Appalachia, colorectal cancer screening rates were higher in the population with multiple morbidities or diseases compared to those who had no morbidities at all.

Many physicians recommend unnecessary cancer screening for the old and sick

June 4, 2012
A significant number of physicians would recommend colorectal cancer screening for elderly patients with a severe illness, according to David Haggstrom from the Richard L. Roudebush VA Medical Center in Indianapolis in the ...

Recommended for you

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy

July 19, 2017
A novel screening method developed by a team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing technology to test the function of thousands of tumor genes in mice—has ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.